Sanyou Bio recently announced a move into its new 10,000-square-meter R&D building at Shanghai headquarters. As the core of Sanyou Bio's global strategy, the Shanghai headquarters integrates both an operational centre with a high-level R&D hub. It will lay a solid foundation for attracting top talents, absorbing cutting-edge technology, and expanding into international markets, opening a new chapter in global development.

In addition to the R&D building, Sanyou Bio has established a pilot production base of over 5,000 square meters through both self-construction and integration to accelerate the clinical transformation of innovative molecules. 

Sanyou Bio has established an integrated R&D laboratory for innovative biologics, which is centered on advanced and comprehensive facilities and equipment, and fully covers the entire process needs of biologic drug development. The highlight of the laboratory is its extensive equipment lineup, with a total of over 1,200 units and an investment of over $15 million in facilities and equipment, ranging from basic to cutting-edge experimental equipment.

The company has also established multiple overseas R&D offices or business hubs in global biopharmaceutical innovation centres such as Philadelphia, Boston, San Diego in the United States, and London in the United Kingdom. These hubs serve not only as bridges for close collaboration with international clients and suppliers, but also as key windows for the company to absorb cutting-edge global technologies and expand international market presence.